Cleared Traditional

K945571 - ABBOTT TEST PACK STREP A TEST

K945571 is an FDA 510(k) clearance for ABBOTT TEST PACK STREP A TEST, manufactured by Abbott Laboratories. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 280-day FDA review.

K945571 · Abbott Laboratories · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
280d
Days
Class 1
Risk

K945571 is an FDA 510(k) clearance for the ABBOTT TEST PACK STREP A TEST. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on August 14, 1995 after a review of 280 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K945571

510(k) Number K945571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 1994
Decision Date August 14, 1995
Days to Decision 280 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
178d slower than avg
Panel avg: 102d · This submission: 280d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 81
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K945571.
MEDIX BIOTECH STREP A ANTIGEN DETECTION TEST (MODIFICATION)
K952873 · Medix Biotech, Inc. · Sep 1995
QUIKSTRIP ONESTEP STREP A TEST IMMUNOCHROMA ASSAU
K935475 · Syntron Bioresearch, Inc. · Aug 1995
QUIKPAC II ONESTEP STREP A IMMUNOCHROMATOGRAPHIC ASSAY
K935554 · Syntron Bioresearch, Inc. · Aug 1995
PROLEX (STREPTOCCAL GROUPING LATEX KIT)
K934383 · Pro-Lab, Inc. · Jan 1995
REMEL RIM STREPTOCOCCUS GROUPING LATEX AGGLUTINATION TEST
K942093 · Medical Diagnostic Technologies, Inc. · Nov 1994
MEDIX BIOTECH BESTEST STREP A CAT. NO. BSF1010
K932482 · Medix Biotech, Inc. · Jul 1994